Evidence map›Paper›PMID 20655306›Full record

ArticleExperimental and molecular pathology2010

Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.

Rebecca A Rozich, David R Mills, Kate E Brilliant, Helen M Callanan, DongQin Yang, Umadevi Tantravahi, Douglas C Hixson

Abstract read
In one paragraph

Article in Experimental and molecular pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2013
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rebecca A RozichDepartment of Medicine, Division of Hematology and Oncology, Rhode Island Hospital/The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
David R Mills
Kate E Brilliant
Helen M Callanan
DongQin Yang
Umadevi Tantravahi
Douglas C Hixson
Brown University · USRhode Island Hospital · US

Funding

UCP2 expression in colon cancerP20RR017695 · NCRR · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI RAMRATNAM, BHARAT · 2002 to 2011
$15.0M
Genesis of Liver Carcinomas with Oval Cell TraitsR01CA093840 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI MILLS, DAVID · 2002 to 2011
$3.1M
CELLULAR ORIGINS OF LIVER CANCERR01CA042715 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI HIXSON, DOUGLAS CARTER · 1985 to 2008
$2.3M
NCI NIH HHS CA42715NCI NIH HHS CA93840NCI NIH HHS R01 CA042715NCI NIH HHS R01 CA093840NCRR NIH HHS P20 RR017695PHS HHS RRP20RR017695
6 · The paper itself

Abstract

Cholangiocarcinoma, a severe form of biliary cancer, has a high mortality rate resulting partially from the advanced stage of disease at earliest diagnosis. A better understanding of the progressive molecular and cellular changes occurring during spontaneous cholangiocarcinogenesis is needed to identify potential biomarkers for diagnosis/prognosis or targets for novel therapeutics. Here, we show that with continued passage (p) in vitro, rat bile duct epithelial cells (BDEC) accumulated neoplastic characteristics that by mid-passage (p31-85) included alterations in morphology, increased growth rate, growth factor independence, decreased cell adhesion, loss of cholangiocyte markers expressed at low passage (p<30), and onset of aneuploidy. At high passage (p>85), BDEC cultures showed increasing numbers of cells expressing activated, tyrosine phosphorylated ErbB-2/Neu, a receptor tyrosine kinase previously reported to be at elevated levels in cholangiocarcinomas. Enrichment for high passage ErbB-2/Neu-positive cells yielded several anchorage-independent sub-lines with elevated levels of activated ErbB-2/Neu and increased expression of cyclooxygenase-2 (COX-2). When injected into immunodeficient beige/nude/xid mice, these sub-lines formed poorly differentiated cystic tumors strongly positive for rat cholangiocyte markers, a finding consistent with a previous report showing the susceptibility of high passage, non-tumorigenic BDEC to transformation by activated ErbB-2/Neu. Mid passage BDEC, in contrast, were resistant to the transforming activity of activated ErbB-2/Neu and remained anchorage dependent in vitro and non-tumorigenic in vivo following stable transfection. Based on these findings, we concluded that during progression to high passage, cultured BDEC undergo preneoplastic changes that enhance their susceptibility to transformation by ErbB-2/Neu. The ability to generate cells at different points in the process of spontaneous neoplastic transformation offers a valuable model system for identifying molecular features that determine whether over-expression of activated ErbB-2/Neu is necessary and sufficient to induce neoplastic conversion.

Indexed as

AnimalsBile Duct NeoplasmsCell Culture TechniquesCell SeparationCell Transformation, NeoplasticCholangiocarcinomaEpithelial CellsErb-b2 Receptor Tyrosine KinasesFlow CytometryFluorescent Antibody TechniqueImmunoblottingMiceRatsTransfectionErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID20655306
PMCPMC4012332
OpenAlexW2055028892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.